Intravenous Infusion of Esketamine in Combination With Pulsed Radiofrequency for Trigeminal Postherpetic Neuralgia
This trial's primary objective is to compare the analgesic efficacy of esketamine in combination with pulsed radiofrequency (PRF) against that of PRF monotherapy in patients with trigeminal postherpetic neuralgia (TPHN).
- Status
- planned
- Institution
- Beijing Tiantan Hospital
- Start date
- 2025-04-01
- End date
- 2026-07-01
- Registry ID
- NCT06914180
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.